• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 35
  • 17
  • 4
  • 3
  • 2
  • 2
  • 1
  • Tagged with
  • 81
  • 20
  • 16
  • 13
  • 11
  • 9
  • 9
  • 9
  • 7
  • 7
  • 7
  • 6
  • 6
  • 6
  • 6
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
71

Expressão da proteína prion celular no modelo da pilocarpina de epilepsia do lobo temporal

Rockenbach, Isabel Cristina January 2010 (has links)
Ratos que não expressam a proteína prion celular (PrPc) são mais sensíveis a crises epilépticas induzidas por diferentes protocolos. O hipocampo desses animais apresenta um brotamento supragranular de fibras musgosas semelhante ao observado em pacientes com epilepsia de lobo temporal relacionada a esclerose hipocampal (ELT-EH). Esses achados sugerem que a PrPc pode estar envolvida na epileptogênese da ELT-EH. Nós estudamos nessa tese a localização imunoistoquímica da PrPc no hipocampo de animais submetidos ao modelo de epilepsia de lobo temporal por pilocarpina (MELTP)em diferentes tempos de status epilepticus em ratos. Nesse trabalho induzimos estado de mal epileptico (EE) com o uso de pilocarpina em três diferentes grupos de ratos Wistar adultos. Os animais foram sacrificados 18 horas, 5 dias e 2 meses após a indução do EE. Os resultados foram comparados com cérebros controles de ratos que receberam injeções de solução salina. As lâminas foram processadas para coloração por hematoxilinaeosina, imunohistoquímica e neo-Timm. Observamos um aumento da expressão de PrPc nas regiões CA1 e CA3 do hipocampo 18 horas depois da injeção de pilocarpina. Essa expressão aumentada persistiu na região CA1 no quinto dia após a injeção. Não observamos diferenças significativas na expressão de PrPc durante a fase aguda do MELTP nas regiões CA2 e granular do hipocampo. No grupo crônico (2 meses) a PrPc foi observada na mesma localização em que se observou brotamento de fibras musgosas. Concluímos com esse trabalho que a expressão da PrPc é diferente nas diversas fases do modelo de epilepsia induzido por pilocarpina. A expressão transitória da proteína prion durante a fase aguda do modelo pode refletir mudanças de expressão visando tornar as células mais resistentes ao dano induzido pelas crises convulsivas. Alternativamente, essa expressão aumentada pode estar relacionadas à apotose ou então às fases iniciais da neuroplasticidade. A expressão de PrPc na mesma região dos brotamentos de fibras musgosas na fase crônica pode estar relacionada à neuroplasticidade, epileptogênese, neurotransmissão ou, ainda, estar implicada na proteção celular contra crises convulsivas recorrentes. Devido aos diversos achados relacionados a PrPc, sugerimos que o modelo de epilepsia do lobo temporal induzido pela pilocarpina possa ser um interessante modelo para o estudo do papel fisiológico da PrPc. / Mice lacking cellular prion protein (PrPc) are more sensitive to seizures induced by four different pharmacological protocols. The hippocampal formation of these animals exhibits supragranular mossy fiber sprouting which resembles that observed in patients with mesial temporal lobe epilepsy related to hippocampal sclerosis (MTLEHS). These findings suggest that the PrPc may be involved in epileptogenesis in MTLE-HS. Here we investigated the immunohistochemical localization of the PrPc in the hippocampus of animals submitted to the pilocarpine model of temporal lobe epilepsy (PMTLE). Status epilepticus (SE) was induced with pilocarpine in three different groups of adult Wistar rats. The animals were sacrificed 18 hours, 5 days, and 2 months after SE induction and the results were compared to the respective saline-injected control animals. Slices were processed for hematoxylin-eosin, PrPc immunohistochemistry and neo-Timm .PrPc was increased in the CA1 and in CA3 regions of the hippocampus 18 hours after pilocarpine injection. PrPc continued to be increased in the CA1 region of the hippocampus five days after pilocarpine injection. In the CA2 and granular regions of the hippocampus we did not observe significant differences in PrPc expression during the acute phase of PMTLE. In the chronic group, PrPc was expressed co-localized with mossy fiber sprouting. Cellular prion protein is differentially expressed at different phases of the pilocarpine model of epilepsy. Transient expression of PrPc during the acute phase of the pilocarpine model may reflect changes which may render cells more resistant to seizure-induced damage and may be related to apoptosis or may to the initial phases of neuroplasticity. During the chronic period, PrPc is co-expressed in the same regions of mossy fiber sprouting. In chronic animals, PrPc might be related to neuroplasticity, epileptogenic processes, neurotransmission, or alternatively may be implicated in cellular protection against recurrent seizures.
72

Modélisation de la réplications des Prions : Implication de la dépendance en taille des agrégats de PrP et de l'hétérogénéité des populations cellulaires. / Experimental study and modelisation of prion propagation in a cell population

Lenuzza, Natacha 16 October 2009 (has links)
Les maladies à Prions sont des maladies neurodégénératives fatales, touchant l'homme et l'animal. Même si le risque de transmission de la maladie de la vache folle à l'homme semble maîtrisé, il persiste actuellement un risque de santé publique lié à la transmission iatrogène de cette forme, notamment par transfusion sanguine. Pour contrôler cette transmission, il est donc essentiel de mieux comprendre les mécanismes moléculaires et cellulaires de réplication et de dissémination des Prions. Ces mécanismes de réplication se produisent à des échelles de temps et de taille difficilement accessibles expérimentalement, et ont ainsi fait l'objet de nombreuses modélisations théoriques utiles pour aider à la compréhension des mécanismes. L'objectif de cette thèse est de compléter ces modèles mathématiques, afin d'étudier plus spécifiquement les conséquences dynamiques sur la réplication des Prions, des propriétés de réplication taille-dépendante d'une part, et de l'hétérogénéité des cellules impliquées dans la réplication d'autre part. Dans un premier temps, nous avons généralisé un modèle de polymérisation nucléée pour prendre en compte un taux d'élongation des fibrilles dépendant de leur taille. Nous avons principalement déduit de cette étude que la distribution en taille des agrégats semble une donnée expérimentale très informative sur les mécanismes élémentaires de réplication, au contraire du profil cinétique d'accumulation de la PrPres peu sensibles aux propriétés de réplication taille-dépendantes. Dans un second temps, après une caractérisation expérimentale de l'hétérogénéité cellulaire de réplication, nous avons intégré le mécanisme de réplication intracellulaire à un modèle multicellulaire par automate cellulaire continu stochastique. De manière appliquée, cette étude nous a permis d'identifier des étapes du processus de culture cellulaire critiques pour l'établissement d'une infection chronique, et nous a permis de proposer plusieurs protocoles pour augmenter la sensibilité des cultures cellulaires aux infections à Prions. / Prion diseases are neurodegenerative, fatal and transmissible diseases, with no effective treatment. The risk of transmission of bovine spongiform encephalopathy to humans is now under control ; however the risk of human-to-human transmission of variant Creutzfeldt-Jakob disease via medical treatments (notably through blood transfusion) remains. Thus, understanding cellular and molecular mechanisms responsible for Prion replication and dissemination is critical to efficiently control Prion transmission. The mechanisms of Prion replication are poorly characterised and occur at time and size scale achieved experimentally with difficulty. Thus, mathematical models can help us understand prion multiplication by testing which mechanisms best fit to experimental data. Therefore the objectives of our study are to complete existing mathematical model in order to investigate the size-dependent replicative properties of prion aggregates and the cellular heterogeneity. Firstly, we have extended a previous study of the nucleated polymerization model to take into account size dependent replicative properties of prion aggregates. This is achieved by a choice of coefficients in the model that are not constant. Our results suggest that the size distribution of prion aggregates could be one of the most informative experimental data to study elementary replication mechanisms and to investigate strain phenomenon. Secondly, we have modelled the multicellular dynamics of prion replication by integrating intracellular replication (by nucleated polymerization) into a continuous and stochastic cellular automaton. The model formulation is based on an experimental characterisation of cellular heterogeneity. From an applicative point of view, this theoretical study has allowed us to propose several protocols to increase cell culture sensitivity to prion infection.
73

Expressão da proteína prion celular no modelo da pilocarpina de epilepsia do lobo temporal

Rockenbach, Isabel Cristina January 2010 (has links)
Ratos que não expressam a proteína prion celular (PrPc) são mais sensíveis a crises epilépticas induzidas por diferentes protocolos. O hipocampo desses animais apresenta um brotamento supragranular de fibras musgosas semelhante ao observado em pacientes com epilepsia de lobo temporal relacionada a esclerose hipocampal (ELT-EH). Esses achados sugerem que a PrPc pode estar envolvida na epileptogênese da ELT-EH. Nós estudamos nessa tese a localização imunoistoquímica da PrPc no hipocampo de animais submetidos ao modelo de epilepsia de lobo temporal por pilocarpina (MELTP)em diferentes tempos de status epilepticus em ratos. Nesse trabalho induzimos estado de mal epileptico (EE) com o uso de pilocarpina em três diferentes grupos de ratos Wistar adultos. Os animais foram sacrificados 18 horas, 5 dias e 2 meses após a indução do EE. Os resultados foram comparados com cérebros controles de ratos que receberam injeções de solução salina. As lâminas foram processadas para coloração por hematoxilinaeosina, imunohistoquímica e neo-Timm. Observamos um aumento da expressão de PrPc nas regiões CA1 e CA3 do hipocampo 18 horas depois da injeção de pilocarpina. Essa expressão aumentada persistiu na região CA1 no quinto dia após a injeção. Não observamos diferenças significativas na expressão de PrPc durante a fase aguda do MELTP nas regiões CA2 e granular do hipocampo. No grupo crônico (2 meses) a PrPc foi observada na mesma localização em que se observou brotamento de fibras musgosas. Concluímos com esse trabalho que a expressão da PrPc é diferente nas diversas fases do modelo de epilepsia induzido por pilocarpina. A expressão transitória da proteína prion durante a fase aguda do modelo pode refletir mudanças de expressão visando tornar as células mais resistentes ao dano induzido pelas crises convulsivas. Alternativamente, essa expressão aumentada pode estar relacionadas à apotose ou então às fases iniciais da neuroplasticidade. A expressão de PrPc na mesma região dos brotamentos de fibras musgosas na fase crônica pode estar relacionada à neuroplasticidade, epileptogênese, neurotransmissão ou, ainda, estar implicada na proteção celular contra crises convulsivas recorrentes. Devido aos diversos achados relacionados a PrPc, sugerimos que o modelo de epilepsia do lobo temporal induzido pela pilocarpina possa ser um interessante modelo para o estudo do papel fisiológico da PrPc. / Mice lacking cellular prion protein (PrPc) are more sensitive to seizures induced by four different pharmacological protocols. The hippocampal formation of these animals exhibits supragranular mossy fiber sprouting which resembles that observed in patients with mesial temporal lobe epilepsy related to hippocampal sclerosis (MTLEHS). These findings suggest that the PrPc may be involved in epileptogenesis in MTLE-HS. Here we investigated the immunohistochemical localization of the PrPc in the hippocampus of animals submitted to the pilocarpine model of temporal lobe epilepsy (PMTLE). Status epilepticus (SE) was induced with pilocarpine in three different groups of adult Wistar rats. The animals were sacrificed 18 hours, 5 days, and 2 months after SE induction and the results were compared to the respective saline-injected control animals. Slices were processed for hematoxylin-eosin, PrPc immunohistochemistry and neo-Timm .PrPc was increased in the CA1 and in CA3 regions of the hippocampus 18 hours after pilocarpine injection. PrPc continued to be increased in the CA1 region of the hippocampus five days after pilocarpine injection. In the CA2 and granular regions of the hippocampus we did not observe significant differences in PrPc expression during the acute phase of PMTLE. In the chronic group, PrPc was expressed co-localized with mossy fiber sprouting. Cellular prion protein is differentially expressed at different phases of the pilocarpine model of epilepsy. Transient expression of PrPc during the acute phase of the pilocarpine model may reflect changes which may render cells more resistant to seizure-induced damage and may be related to apoptosis or may to the initial phases of neuroplasticity. During the chronic period, PrPc is co-expressed in the same regions of mossy fiber sprouting. In chronic animals, PrPc might be related to neuroplasticity, epileptogenic processes, neurotransmission, or alternatively may be implicated in cellular protection against recurrent seizures.
74

Functional proteome analysis of age associated PrPC knockout mice liver along with regulatory response of cytoskeleton associated tau protein and fatty liver disease.

Arora, Amandeep Singh 14 April 2015 (has links)
No description available.
75

Blood-Spinal cord-barrier breakdown and prion-like behaviour of mutant huntingtin : shedding light onto new pathological characteristics of Huntington's disease

Sciacca, Giacomo 08 February 2022 (has links)
La maladie de Huntington (MH) est une maladie neurodégénérative qui se manifeste par un vaste répertoire de symptômes moteurs, cognitifs et psychiatriques. La pathologie est causée par une expansion anormale de la queue polyglutamine du gène huntingtine (HTT), qui code pour une protéine ubiquitaire du même nom, et qui possède différentes fonctions dans de nombreux processus cellulaires. La MH résulte de l'expression d'une forme mutée de la protéine huntingtine (mHTT), laquelle peut s'agréger et ainsi interférer avec les processus cellulaires conduisant à la dégénérescence des cellules. Une précédente étude a analysé les conséquences délétères de la présence de mHTT dans la barrière-hémato-encéphalique (BHE), une structure cellulaire localisée au niveau du réseau vasculaire cérébral qui empêche le passage de substances périphériques à l'intérieur du système nerveux central (SNC). Par conséquent, nous avons décidé d'explorer l'existence de déficiences similaires au niveau de la barrière entre sang et la moelle épinière, une structure similaire à la BHE, mais localisée dans le réseau vasculaire de la moelle épinière (blood-spinal cord barrier, BSCB). Nous avons d'abord analysé la distribution, la fréquence et la localisation spécifique des agrégats de mHTT dans des échantillons de moelle épinière provenant de patients MH et de contrôles sains. Ces analyses ont révélé la présence quasi-exclusive de la mHTT dans la substance grise de la moelle épinière. Nous avons par la suite mesuré l'impact de ces agrégats sur les composants protéiques de la BSCB. Notre analyse démontre une dérégulation significative de certaines protéines essentielles formant des jonctions serrées dans la barrière, causant possiblement le phénomène de perméabilité accrue de la BSCB observé chez les patients atteints de la MH. Des études précédentes ont conduit à la théorie selon laquelle la mHTT pourrait se comporter à la manière d'un prion, propageant ainsi la maladie dans le SNC. Nous avons validé cette théorie en utilisant trois approches différentes ; une in vitro et deux in vivo. Trois différents modèles cellulaires humains (SH-SY5Y, THP1, et iGABA) ont été traités avec des fibrilles synthétiques afin d'observer l'effet de fibrilles humaines exogènes de mHTT (Q48) et de huntingtine normale (HTT ; Q25). Nous avons observé que les fibrilles pouvaient être internalisées par ces cellules, induisant des changements morphologiques et de la mort cellulaire. De plus, des changements de niveaux de HTT ont été observés. Au cours des expériences in vivo, des souris adultes sauvages (WT) ont reçu une injection intra-corticale unilatérale de fibrilles synthétiques de fragments N-terminaux de (m)HTT (Q25 et Q48), alors que des souriceaux R6/2 et WT ont reçu une injection intraventriculaire bilatérale. Dans les deux protocoles, les injections de fibrilles Q48 ont conduit à des changements comportementaux et les analyses post-mortem ont révélé que ces fibrilles exogènes étaient capables d'induire et d'exacerber la pathologie. Ces résultats démontrent que la mHTT pourrait se comporter tel un prion, se propageant et aggravant la pathologie dans le SNC. De plus, la démonstration que la mHTT perturbe l'intégrité de la BSCB suggère que l'exacerbation de sa perméabilité pourrait être une route possible de la propagation de la mHTT. / Huntington's disease (HD) is a neurodegenerative disorder that results in a series of motor, cognitive, and psychiatric symptoms. The pathology is caused by abnormal expansion of the polyglutamine tract of the huntingtin gene (HTT), which encodes a ubiquitous protein named huntingtin, and has different functions in several cellular processes. HD results from the expression of a mutated form of the huntingtin protein (mHTT) that forms protein aggregates and disrupts these cellular processes causing neurodegeneration. A previous study analyzed the deleterious consequence of the presence of mHTT on the blood-brain barrier (BBB), a cellular structure located in the brain vasculature that prevents the passage of peripheral substances into the central nervous system (CNS). Therefore, we decided to explore the existence of similar impairments in the blood-spinal cord barrier (BSCB), a structure similar to the BBB, but located in the spinal cord vasculature. To begin with, we analyzed the anatomical distribution, frequency, and specific location of mHTT aggregates in spinal cord samples from HD and healthy control human samples, revealing an almost exclusive presence of mHTT within the grey matter of the spinal cord. We then measured HD impact on the spinal cord vasculature and BSCB permeability. Our analysis showed an increase of the small blood vessel density and the presence of features related to BSCB leakage, such as diffusion of fibrinogen in the surrounding parenchyma and peripheral cells infiltration. Moreover, the measure of the levels of the protein components of the BSCB revealed a downregulation of some essential proteins forming tight junctions in the barrier that is the likely cause of the increased BSCB permeability that we observed in HD patients. Previous studies led to the theory that mHTT might behave in a prion-like fashion spreading and seeding the disease throughout the CNS. We validated this theory using three different approaches; one in vitro and two in vivo. Three different human cell lines (SH-SY5Y, THP1, and iGABA neurons) were treated with synthetic fibrils to observe the effect of exogenous human fibrillar mHTT (Q48) and huntingtin (HTT) (Q25). We observed that the fibrils could be taken up by these cells, subsequently inducing cellular morphological changes and apoptosis. Moreover, changes in HTT levels and sequestration of endogenous HTT within pathological inclusion bodies were observed suggesting a prion-like behavior by mHTT. Subsequently, in in vivo experiments, wild type (WT) adult mice were administered an intracortical unilateral injection of synthetic fibrillar N-terminal fragments of mHTT (Q25 and Q48), while R6/2 and WT pups received a bilateral intraventricular injection. In both protocols, the Q48 injections resulted in behavioral changes and the appearance of features HD-related. The post-mortem analysis revealed that the exogenous fibrils were able to spread through the brain inducing and exacerbating the pathology in both animal models. These results demonstrate that mHTT might behave in a prion-like fashion, spreading and exacerbating the disease throughout the CNS. Moreover, the demonstration that mHTT disrupts the integrity of the BSCB suggests that the increased permeability could be a route of mHTT propagation.
76

PRION CHARACTERIZATION USING CELL BASED APPROACHES

Khaychuk, Vadim 01 January 2012 (has links)
Prions are the causative agents of a group of lethal, neurodegenerative conditions that include sheep scrapie, bovine spongiform encephalopathy (BSE), and human Creutzfeldt-Jakob disease (CJD). Prions are derived from the conversion of a normal, primarily alpha-helical, cellular prion protein (PrPC), to an infectious, beta sheet-rich conformer (PrPSc). Many unresolved issues surround the process of PrP conversion, and we know very little about cellular responses to these unique pathogens. Our lack of knowledge relates, in part, to the difficulty of infecting cells in vitro with prions. While expression of PrPC is an absolute requirement for prion propagation, I show here that not all cells that express PrPC are capable of propagating PrPSc. The goal of this thesis is to understand the role that host factors play in sustaining prion infection and to develop systems in which the cellular response to prion infection can be assessed. We hypothesize that cellular permissiveness to prion infectivity is co-dependent on unidentified additional cellular factors. To study the role of PrPC expression in susceptibility to prion infectivity, and identify these cofactors in cell culture, we utilized cells which fail to express endogenous PrPC, but become susceptible to prions following stable expression of PrPC. Following transfection of a species specific PrP expression construct and isolation of single cell clones, we assessed PrP expression and susceptibility to prion infectivity by measuring accumulation of protease resistant PrPSc. Differential gene expression studies suggest significant transcriptional differences between susceptible and resistant clones. Using three independent gene expression databases our analyses suggest that the resistant transcriptional profile favors cell division/cycle and chromosomal regulation pathways, while the sensitive transcriptional profile is involved in protein homeostasis and quality control. The results of these studies will not only lead to a greater understanding of PrP cell biology and the mechanisms of prion pathogenesis, but should ultimately lead to sensitive and expedient methods for detecting and characterizing prion infectivity from a wide range of sources.
77

Effects of small molecule modulators and Phospholipid Liposomes on βeta-amyloid (1-40) Amyloidogenesis

Unknown Date (has links)
Beta-Amyloid (1-40) (Aβ40) is an aggregation prone protein, which undergoes a nucleation-dependent aggregation process causing the pathological neurodegeneration by amyloid plaque formation implicated in Alzheimer’s disease. In this thesis, we investigated the effects of small molecule modulators extracted from the marine invertebrate Pseudopterogorgia elisabethae on the Aβ40 amyloidogenic process using in- vitro ThT fluorescence assay and atomic force microscopy. We also investigated the effects of neutral and anionic phospholipid liposomes on Aβ40 aggregation. Our results show that a marine natural product Pseudopterosin-A and its derivatives can suppress and modulate the Aβ40 aggregation process. Furthermore, our results demonstrate that a neutral phospholipid liposome inhibits Aβ40 fibril formation, whereas the anionic liposomes promote it. / Includes bibliography. / Thesis (M.S.)--Florida Atlantic University, 2015 / FAU Electronic Theses and Dissertations Collection
78

Ion-specific and water-mediated effects on protein physical stability

Rubin, Jonathan 20 March 2013 (has links)
Protein aggregation and physical stability are perpetual concerns in medicine and industry. Misfolded protein can form ordered protein aggregates, amyloids, which are associated with a host of neurodegenerative diseases in mammals and control heritable traits in fungi and yeast. Industrially, amorphous aggregates reduce the efficacy of protein-based therapeutics and activity of enzymes during production and storage. This work studies ion-specific and solvent-based effects on protein physical stability. We show that ion-specificity significantly affects amyloid formation kinetics, aggregate morphology, thermostability, frangibility, and, most intriguingly, prion infectivity in vivo. Forming amyloid in chaotropic or kosmotropic solutions generates predominately weak or strong prion variants, respectively. Ion-specific effects also influenced amorphous aggregation of model proteins and antibodies. To quantify protein - protein stability/affinity, we developed a rapid and reliable diffusion-based technique. Our technique was able to resolve relative differences in colloidal stability between various saline and saccharide solutions. In all, this dissertation expands our understanding of ion-specific and water-mediated interactions with prion proteins and protein dispersions.
79

Mort neuronale et maladies à prions / Neuronal death and prion diseases

Ragagnin, Audrey 11 December 2014 (has links)
La conversion conformationnelle de la protéine prion cellulaire PrPC neuroprotectrice en protéine prion PrPSc infectieuse et pathogène caractérise les maladies à prions. Dans le cerveau infecté par les prions, la perte de PrPC, le gain de PrPSc neurotoxique et l’inflammation concourent à la mort neuronale par des mécanismes encore mal connus.Ces travaux valident les cultures organotypiques de cervelet de souris comme système expérimental ex vivo favorable à l’étude de ces mécanismes et montrent que l’absence de PrPC aussi bien que PrPSc activent des mécanismes apoptotiques et autophagiques qui conduisent à la mort des cellules de Purkinje du cervelet. Une deuxième étude in situ chez la souris montre que la compartimentation anatomo-fonctionnelle du cervelet est un paramètre endogène de la pathogenèse des prions de tremblante 22L. Une troisième série d’expériences in situ montre que les prions provoquent l’augmentation du récepteur TNFR1 de la cytokine pro-inflammatoire TNF-α à la membrane des astrocytes enveloppant les synapses excitatrices des cellules de Purkinje dans le cortex cérébelleux de souris infectées. Ceci implique une composante astrocytaire dans la réaction des complexes synaptiques aux prions. / The conversion of the protective cellular prion protein PrPC into an infectious, neurotoxic conformer PrPSc is a feature of prion diseases. In the prion-diseased brain, the loss of PrPC, the production of pathogenic PrPSc and inflammation contribute to neuronal death by still unknown mechanisms.The present results validate cerebellar organotypic cultures as a valuable experimental system to study ex vivo these mechanisms and provide insight into the apoptotic and autophagic processes activated by the absence of PrPC in Prnp-deficient mice and by PrPSc prions and lead to the death of the cerebellar Purkinje cells. A second line of research in situ showed that the anatomo-functional compartmentation of the mouse cerebellum is an endogenous parameter of the pathogenesis of the 22L scrapie prions. Finally, another in situ approach revealed that prions increase the levels of TNFR1, a receptor for the pro-inflammatory cytokine TNF-α at the membrane of the astrocytes enveloping Purkinje cell excitatory synapses in the cerebellar cortex of infected mice. This implies that the response of synaptic complexes to prions involves a glial component.
80

Prion-like Properties in Vesicle Trafficking

McKeith Pearson II (11205306) 20 August 2023 (has links)
<p>Vesicle trafficking is an important process critical for secretory and endocytic purposes, but it is also crucial for cell homeostasis, <i>e.g.,</i> for maintenance of organelle identity and recycling of membrane components.</p><p>The endomembrane-located adaptor protein Epsin R (Epsin-Related protein) is believed to be important for recycling of SNARES like Vti1b from endosomes to the trans Golgi network (TGN), although its involvement in TGN to endosome transport has been also proposed. Further highlighting its impact in cellular and organismal physiology, certain <i>EPSIN R</i> SNPs have been linked to schizophrenia and Epsin R deficiencies correlate with other pathological conditions related to epidermis homeostasis such as psoriasis and eczema.</p><p>Epsin R belongs to the conserved Epsin family of adaptors and as such it presents a characteristic Epsin N-Terminal Homology (ENTH) domain and a largely unstructured C-terminus. The latter contains binding motifs for important elements of the vesicle trafficking machinery.</p><p>Here we identified a C-terminal region of Epsin R with prion-like characteristics (Prion Forming Region or PFR). We found that GFP-Epsin R is localized in intracellular punctate structures colocalizing with different intracellular markers; however, in contrast to other epsin family members, Epsin R displayed puncta of different size and with different protein content with a substantial contribution of large/bright particles. Importantly, the C-terminal Epsin R’s PFR was required for Epsin R localization and for the formation of large and bright puncta. Further, these structures displayed characteristics shared with other prion-like proteins. Our results therefore suggest that Epsin R possesses PFR-dependent prion properties that play an important role in this adaptor’s localization and function.</p><p>We propose a model in which prion-like proteins like Epsin R can rapidly and stably self-assemble at vesicle budding sites. These proteins would accelerate the formation of vesicle trafficking machinery and the recruitment of cargo. We also speculate that oligomerizing, self-templating reactions would occur under strict control of several cellular factors such as chaperones and post-translational modifications (<i>e.g.,</i> phosphorylation, ubiquitination, etc.) to assure quick and <i>reversible</i> association of prion-like proteins.</p>

Page generated in 0.0639 seconds